Because the effects of atropine are dose related, at what dose of atropine would the nurse expect to see a patient having difficulty speaking?
A) 0.5 mg
B) 1.0 mg
C) 2.0 mg
D) 5.0 mg
D
Feedback:
Toxicity of atropine is dose related. With 5.0-mg dosage, the nurse would expect marked speech disturbances, difficulty swallowing, restlessness, fatigue, headache, dry and hot skin, difficulty voiding, and reduced intestinal peristalsis. With 0.5-mg dosage of atropine, slight cardiac slowing, dryness of the mouth, and inhibition of sweating would be noticed. Definite dryness of the mouth and throat, thirst, rapid heart rate, and pupil dilation would be evident with 1.0-mg dosage. With 2.0-mg dosage, the nurse would note rapid heart rate, palpitations, marked mouth dryness, dilated pupils, and some blurring of vision.
You might also like to view...
An IV is infusing at 25 gtt/min. If the drop factor is 10 gtt/mL, what would this rate of flow equal in mL/h?
1. 250 mL/h 2. 4.2 mL/h 3. 150 mL/h 4. 15,000 mL/h
The nurse is caring for a patient transferred from the local prison who was arrested and convicted of child sexual abuse. The nurse feels disgust for the patient's behavior but can avoid being judgmental by understanding what?
1. Motivation 2. State laws 3. The patient's social history 4. Code of ethics
The plaintiff was injured by a defective intravenous catheter. In order to win a product liability case, what must the plaintiff prove first?
1. The intravenous catheter was defective. 2. The intravenous catheter was used incorrectly. 3. The intravenous catheter was sold to him. 4. The hospital purchases the poorly manufactured intravenous catheters.
The nurse is caring for a 13-year-old boy with acute myelogenous leukemia who is having body image problems due to the effects of chemotherapy. Which of the following interventions will best help the teen's sense of control?
A) Involving the boy in decisions whenever possible B) Acknowledging the boy's feelings of anger with the disease C) Providing realistic expectations of treatments and outcomes D) Recognizing abilities that are unaffected by the disease